BioCentury | Jul 30, 2012
Clinical News

Durezol regulatory update

...Durezol through its 2011 acquisition of Alcon Inc. , which acquired exclusive, U.S. rights from Sirion Therapeutics Inc....
BioCentury | May 21, 2012
Clinical News

Peregrine preclinical data

...Bausch + Lomb Inc. (Rochester, N.Y.) has rights to market Zirgan in the U.S. from Sirion Therapeutics Inc....
BioCentury | Jan 30, 2012
Clinical News

Durezol regulatory update

...Durezol through its 2011 acquisition of Alcon Inc. , which acquired exclusive, U.S. rights from Sirion Therapeutics Inc....
BioCentury | Feb 21, 2011
Company News

SARcode management update

...Inflammation, Ophthalmic Hired: Todd Creech as CFO and VP of business development, formerly CFO of Sirion Therapeutics Inc....
BioCentury | Sep 13, 2010
Clinical News

Fenretinide: Additional Phase IIb data

...the American Academy of Ophthalmology meeting in Chicago next month. ReVision acquired oral fenretinide from Sirion Therapeutics Inc....
BioCentury | Jun 14, 2010
Company News

Sirion, Bausch + Lomb sales and marketing update

...but subsequently said it was revaluating the deal (see BioCentury, April 5, & May 10). Sirion Therapeutics Inc....
BioCentury | May 10, 2010
Company News

Sirion sales and marketing update

...that targets viral DNA. Sirion said Alcon is evaluating the acquisition (see BioCentury, Jan. 25). Sirion Therapeutics Inc....
BioCentury | Apr 5, 2010
Company News

Alcon, Sirion sales and marketing update

...gel. Financial terms were not disclosed (see BioCentury Jan. 25). Alcon Inc. (NYSE:ACL), Hunenberg, Switzerland Sirion Therapeutics Inc....
BioCentury | Mar 18, 2010
Distillery Therapeutics

Indication: Neurology

...developing a clinical trial protocol to test the therapeutic potential of fenretinide in acute SCI. Sirion Therapeutics Inc....
BioCentury | Jan 25, 2010
Company News

Alcon, Sirion sales and marketing update

...not disclosed. Sirion would not comment on its future plans. Alcon Inc. (NYSE:ACL), Hunenberg, Switzerland Sirion Therapeutics Inc....
Items per page:
1 - 10 of 39
BioCentury | Jul 30, 2012
Clinical News

Durezol regulatory update

...Durezol through its 2011 acquisition of Alcon Inc. , which acquired exclusive, U.S. rights from Sirion Therapeutics Inc....
BioCentury | May 21, 2012
Clinical News

Peregrine preclinical data

...Bausch + Lomb Inc. (Rochester, N.Y.) has rights to market Zirgan in the U.S. from Sirion Therapeutics Inc....
BioCentury | Jan 30, 2012
Clinical News

Durezol regulatory update

...Durezol through its 2011 acquisition of Alcon Inc. , which acquired exclusive, U.S. rights from Sirion Therapeutics Inc....
BioCentury | Feb 21, 2011
Company News

SARcode management update

...Inflammation, Ophthalmic Hired: Todd Creech as CFO and VP of business development, formerly CFO of Sirion Therapeutics Inc....
BioCentury | Sep 13, 2010
Clinical News

Fenretinide: Additional Phase IIb data

...the American Academy of Ophthalmology meeting in Chicago next month. ReVision acquired oral fenretinide from Sirion Therapeutics Inc....
BioCentury | Jun 14, 2010
Company News

Sirion, Bausch + Lomb sales and marketing update

...but subsequently said it was revaluating the deal (see BioCentury, April 5, & May 10). Sirion Therapeutics Inc....
BioCentury | May 10, 2010
Company News

Sirion sales and marketing update

...that targets viral DNA. Sirion said Alcon is evaluating the acquisition (see BioCentury, Jan. 25). Sirion Therapeutics Inc....
BioCentury | Apr 5, 2010
Company News

Alcon, Sirion sales and marketing update

...gel. Financial terms were not disclosed (see BioCentury Jan. 25). Alcon Inc. (NYSE:ACL), Hunenberg, Switzerland Sirion Therapeutics Inc....
BioCentury | Mar 18, 2010
Distillery Therapeutics

Indication: Neurology

...developing a clinical trial protocol to test the therapeutic potential of fenretinide in acute SCI. Sirion Therapeutics Inc....
BioCentury | Jan 25, 2010
Company News

Alcon, Sirion sales and marketing update

...not disclosed. Sirion would not comment on its future plans. Alcon Inc. (NYSE:ACL), Hunenberg, Switzerland Sirion Therapeutics Inc....
Items per page:
1 - 10 of 39